Abstract
Purpose
Atrial high-rate episodes (AHREs) recorded with cardiac implantable electronic devices (CIEDs) have been associated with the development of clinical atrial fibrillation (AF) and increase in stroke and death risk. We sought to perform a systematic review with a meta-analysis to evaluate the prevalence of AHREs detected by CIEDs, their association with stroke risk, development of clinical AF, and mortality among patients without a documented history of AF.
Methods
We searched several databases, ClinicalTrials.gov, references of reviews, and meeting abstract books without any language restrictions up to 9 September 2020. We studied patients with CIEDs in whom AHREs were detected. Exclusion criterion was AF history. Our primary outcome was the risk of ischemic stroke in patients with AHREs.
Results
We deemed eligible eight studies for the meta-analysis enrolling a total of 4322 patients with CIED and without a documented AF history. The overall AHRE incidence ratio was estimated to be 17.56 (95% CI, 8.61 to 35.79) cases per 100 person-years. Evidence of moderate certainty suggests that patients with documented AHREs were 4.45 times (95% CI 2.87–6.91) more likely to develop clinical AF. Evidence of low confidence suggests that AHREs were associated with a 1.90-fold increased stroke risk (95% CI 1.19–3.05). AHREs were not associated with a statistically significant increased mortality risk.
Conclusion
The present systematic review and meta-analysis demonstrated that among patients without a documented history of AF, the detection of AHREs by CIEDs was associated with significant increased risk of clinical AF and stroke.
Registration Number (DOI)
Available in https://doi.org/10.17605/OSF.IO/ZRF6M.
Similar content being viewed by others
Data Availability
The data underlying this article are available in the article and in its online supplementary material, and its protocol can be found in https://doi.org/10.17605/OSF.IO/ZRF6M.
Code Availability
Not applicable.
Abbreviations
- AF:
-
Atrial fibrillation
- AHREs:
-
Atrial high-rate episodes
- CIED:
-
Cardiac implantable electronic devices
- CIs:
-
95% Confidence intervals
- GRADE:
-
Grading of Recommendations, Assessment, Development and Evaluations
- ICD:
-
Implantable cardioverter defibrillators
- ICM:
-
Implantable cardiac monitors
- NOS:
-
Newcastle-Ottawa Scale
- OR:
-
Odds ratios
- OAC:
-
Oral anticoagulant
- PRISMA:
-
Preferred Reporting Items for Systematic reviews and Meta-Analysis
- RCTs:
-
Randomized control trials
- RoB:
-
Risk of bias
- TIA:
-
Transient ischemic attack
References
Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–47.
Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–7.
Gonzalez M, Keating RJ, Markowitz SM, et al. Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers. Heart Rhythm. 2014;11(12):2214–21.
Witt CT, Kronborg MB, Nohr EA, Mortensen PT, Gerdes C, Nielsen JC. Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy. Heart Rhythm. 2015;12(12):2368–75.
Bertaglia E, Blank B, Blomstrom-Lundqvist C, et al. Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence. Europace. 2019;21(10):1459–67.
Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120–9.
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;42(5):373–498.
Kirchhof P, Blank BF, Calvert M, et al. Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J. 2017;190:12–8.
Lopes RD, Alings M, Connolly SJ, et al. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial. Am Heart J. 2017;189:137–45.
Mahajan R, Perera T, Elliott AD, et al. Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis. Eur Heart J. 2018;39(16):1407–15.
Khan AA, Boriani G, Lip GYH. Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation? Clin Res Cardiol. 2020;109(4):409–16.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
Lamassa M, Di Carlo A, Pracucci G, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke. 2001;32(2):392–8.
Cook DA, Reed DA. Appraising the quality of medical education research methods: the medical education research study quality instrument and the Newcastle-Ottawa Scale-Education. Acad Med. 2015;90(8):1067–76.
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.
Schwarzer G. Meta: an R package for meta-analysis. R News. 2007;7:40–5.
Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29(29):3046–67.
Julious SA. Two-sided confidence intervals for the single proportion: comparison of seven methods by Robert G. Newcombe, Statistics in Medicine 1998;17:857–872. Stat Med. 2005;24(21):3383–4.
Schwarzer G, Chemaitelly H, Abu-Raddad LJ, Rücker G. Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions. Res Synth Methods. 2019;10(3):476–83.
Li YG, Miyazawa K, Pastori D, Szekely O, Shahid F, Lip GYH. Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: the West Birmingham Atrial Fibrillation Project. Int J Cardiol. 2019;292:126–30.
Benezet-Mazuecos J, Iglesias JA, Cortés M, et al. Silent atrial fibrillation in pacemaker early post-implantation period: an unintentionally provoked situation? Europace. 2018;20(5):758–63.
Marinheiro R, Parreira L, Amador P, et al. Clinical impact of oral anticoagulation in patients with atrial high-rate episodes. J Stroke Cerebrovasc Dis. 2019;28(4):971–9.
Nishinarita R, Niwano S, Fukaya H, et al. Burden of implanted-device-detected atrial high-rate episode is associated with future heart failure events- clinical significance of asymptomatic atrial fibrillation in patients with implantable cardiac electronic devices. Circ J. 2019;83(4):736–42.
O’Neill J, Jegodzinski L, Tayebjee MH. Incidence of subclinical atrial fibrillation in a South Asian population. Pacing Clin Electrophysiol. 2018;41(12):1600–5.
Camm AJ, Simantirakis E, Goette A, et al. Atrial high-rate episodes and stroke prevention. Europace. 2017;19(2):169–79.
Van Gelder IC, Healey JS, Crijns HJGM, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017;38(17):1339–44.
Author information
Authors and Affiliations
Contributions
ID and MG proposed the structure of the paper, critically appraised the paper, and were the major contributors in writing the manuscript. DT, PA, and CKA screened all titles and abstracts and perused full texts for eligible records; PS and KN independently extracted data from eligible studies; SS and SD assessed risk of bias and evaluated the certainty in our estimates using the GRADE approach; IF and EA proposed the statistical analysis; VK, GG, SP, KG, and KT critically appraised the paper and made the final suggestions. All authors read and approved the final manuscript.
Ethics declarations
Ethics Approval and Consent to Participate
Not applicable.
Informed Consent
No humans were involved in this study.
Consent for Publication
Not applicable.
Research Involving Human Participants and/or Animals
Not applicable.
Conflict of Interest
The authors declare no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 2319 kb)
Rights and permissions
About this article
Cite this article
Doundoulakis, I., Gavriilaki, M., Tsiachris, D. et al. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovasc Drugs Ther 36, 951–958 (2022). https://doi.org/10.1007/s10557-021-07209-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10557-021-07209-8